Cargando…
Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone
BACKGROUND: The Epipen® Jr and Allerject® 0.15 mg are currently the most commonly prescribed epinephrine auto-injectors (EAIs) for the management of anaphylaxis in pediatric patients in North America and Canada. To ensure rapid absorption, it should be administered intramuscularly into the anterolat...
Autores principales: | Kim, Laura, Nevis, Immaculate FP, Tsai, Gina, Dominic, Arunmozhi, Potts, Ryan, Chiu, Jack, Kim, Harold L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126643/ https://www.ncbi.nlm.nih.gov/pubmed/25110478 http://dx.doi.org/10.1186/1710-1492-10-40 |
Ejemplares similares
-
Do epinephrine auto-injectors have an unsuitable needle length for young children?
por: Kim, Laura, et al.
Publicado: (2014) -
Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy
por: Tsai, Gina, et al.
Publicado: (2014) -
Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?
por: Dreborg, Sten, et al.
Publicado: (2016) -
Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?
por: Dreborg, Sten, et al.
Publicado: (2017) -
CSACI position statement: epinephrine auto-injectors and children < 15 kg
por: Halbrich, Michelle, et al.
Publicado: (2015)